Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZFP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FMC1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | NRL | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | BCOR | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | KIAA2026 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NFKB2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CEP95 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | RP11-212D19.4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RPUSD2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ZNF219 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |